PMA device
Pepgen P-15 Dental Bone Grafting Material with Biologic Component
Ceramed Corp. · Bone Grafting Material, Dental, With Biologic Component (NPZ, Class III) · First FDA decision Jun 14, 2002, newest Oct 5, 2006Gum diseaseTooth loss and dental implants
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
0
Naming "Pepgen P-15"
MAUDE reports
2
Brand "Pepgen P-15", since 2015
PubMed studies
36
Mentioning "Pepgen P-15"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Pepgen P-15 Dental Bone Grafting Material with Biologic Component
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
P990033-S008 · Decided Oct 5, 2006 · 36 days after receipt · Normal 180 Day Track No User Fee
Device type: Bone grafting material, dental, with biologic component (NPZ) · Dentistry & Oral Surgery
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Pepgen P-15", any status and sponsor, newest update first.
No registered device study names "Pepgen P-15".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Pepgen P-15", and for the whole product code for context.
This brand
2 reports: 0 malfunction, 2 injury, 0 death
Whole product code NPZ
34 reports: 0 malfunction, 33 injury, 0 death
Newest reports for this brand
- PEPGEN P-15Injury
DENTSPLY TULSA DENTAL SPECIALTIES
2320721-2015-00008 · Received Jul 29, 2015
Device type: Bone Grafting Material, Dental, With Biologic Component (NPZ)
Device problem as coded: Migration or Expulsion of Device
Patient problem as coded: No Code Available
1 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- PepGen P-15 Putty (0.5cc)Terminated
Z-0579-05 · Started Feb 17, 2005 · Posted by FDA Mar 9, 2005
Reason given: PepGen P-15 Putty kit was labeled with the incorrect expiration date.
Cause as FDA categorized it: Other · Device type: Bone Grafting Material, Dental, With Biologic Component (NPZ)
Published research
The most relevant PubMed records for "Pepgen P-15"[tiab]. The summary above synthesizes these.
- Increased Tgf-beta1 production by rat osteoblasts in the presence of PepGen P-15 in vitro.
Trasatti C, Spears R, Gutmann JL, et al. · J Endod · 2004Research Support, Non-U.S. Gov't
- Comparative assessment of periodontal regeneration in periodontal intraosseous defects treated with PepGen P-15 unaided or in blend with platelet-rich fibrin: A clinical and high-resolution computed tomography scan-assisted volumetric analysis.
Goyal J, Sachdeva S, Salaria SK, et al. · J Indian Soc Periodontol · 2020
- Sinus augmentation with bovine hydroxyapatite/synthetic peptide in a sodium hyaluronate carrier (PepGen P-15 Putty): a clinical investigation of different healing times.
Butz F, Bächle M, Ofer M, et al. · Int J Oral Maxillofac Implants · 2011Clinical Trial, Research Support, Non-U.S. Gov't
- Clinical, radiographic, histologic, and histomorphometric comparison of PepGen P-15 particulate and PepGen P-15 flow in extraction sockets: a same-mouth case study.
Hahn J, Rohrer MD, Tofe AJ · Implant Dent · 2003Case Reports, Comparative Study
- A histomorphogenic analysis of bone grafts augmented with adult stem cells.
Smiler D, Soltan M, Lee JW · Implant Dent · 2007Case Reports
- Comparison of bone grafting materials in human extraction sockets: clinical, histologic, and histomorphometric evaluations.
Thompson DM, Rohrer MD, Prasad HS · Implant Dent · 2006Comparative Study
- Cortical bone regeneration with a synthetic cell-binding peptide: a histologic and histomorphometric pilot study.
Scarano A, Iezzi G, Petrone G, et al. · Implant Dent · 2003Research Support, Non-U.S. Gov't
- A study of biologically active peptide sequences (P-15) on the surface of an ABM scaffold (PepGen P-15) using AFM and FTIR.
Hole BB, Schwarz JA, Gilbert JL, et al. · J Biomed Mater Res A · 2005Comparative Study
- Maxillary sinus augmentation using a synthetic cell-binding peptide: a histologic and transmission electron microscopy case study in man.
Degidi M, Scarano A, Iezzi G, et al. · Implant Dent · 2005Case Reports, Research Support, Non-U.S. Gov't
- Resolution of an active peri-implantitis in a chronic steroid user by bone augmentation with PepGen P-15 and a barrier membrane.
Lu SY, Huang CC · J Oral Implantol · 2007Case Reports
- 8-year onlay bone graft and ridge augmentation with PepGen P-15: a clinical and radiographic case study.
Hahn J · Implant Dent · 2004Case Reports
- Human histologic and histomorphometric analysis comparing OsteoGraf/N with PepGen P-15 in the maxillary sinus elevation procedure: a case report.
Krauser JT, Rohrer MD, Wallace SS · Implant Dent · 2000Case Reports, Comparative Study
Other devices of this type
Also filed under product code NPZ.
- Infuse Bone GraftMedtronic, Inc. · PMA 2026
- Gem 21S Growth Factor Enhanced MatrixLynch Biologics, LLC · PMA 2011
- GEM21S Growth Factor Enhanced MatrixLynch Biologics, LLC · PMA 2020
- Gem 21S (Growth Enhanced Matrix)Lynch Biologics, LLC · PMA 2008
- Pepgen P-15, Pepgen P-15 Flow & Pepgen P-15 PuttyCeramed Corp. · PMA 2007
- GEM215 Growth Factor Enhanced MatrixLynch Biologics, LLC · PMA 2020
- Gem 21SGROWTH Factor Enhanced MatrixLynch Biologics, LLC · PMA 2011
- Pepgen 15Ceramed Corp. · PMA 2008
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.